Stem Cell Biology Group, Waghmare Lab, Cancer Research Institute, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai 400085, India.
Stem Cell Biology Group, Waghmare Lab, Cancer Research Institute, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.
EBioMedicine. 2019 Oct;48:364-376. doi: 10.1016/j.ebiom.2019.08.053. Epub 2019 Sep 11.
Tissue stem cells (SCs) and cancer cells proliferation is regulated by many common signalling mechanisms. These mechanisms temporally balance proliferation and differentiation events during normal tissue homeostasis and repair. However, the effect of these aberrant signalling mechanisms on the ultimate fate of SCs and cancer cells remains obscure.
To evaluate the functional effects of Secretory Phospholipase A-IIA (sPLA-IIA) induced abnormal signalling on normal SCs and cancer cells, we have used K14-sPLA-IIA transgenic mice hair follicle stem cells (HFSCs), DMBA/TPA induced mouse skin tumour tissues, human oral squamous cell carcinoma (OSCC) and skin squamous cell carcinoma (SCC) derived cell lines.
Our study demonstrates that sPLA-IIA induces rapid proliferation of HFSCs, thereby altering the proliferation dynamics leading to a complete loss of the slow cycling H2BGFP positive HFSCs. Interestingly, in vivo reversion study by JNK inhibition exhibited a significant delay in post depilation hair growth, confirming that sPLA-IIA promotes HFSCs proliferation through JNK/c-Jun signalling. In a different cellular context, we showed increased expression of sPLA-IIA in human OSCC and mouse skin cancer tissues. Importantly, a xenograft of sPLA-IIA knockdown cells of OSCC and SCC cell lines showed a concomitant reduction of tumour volume in NOD-SCID mice and decreased JNK/c-Jun signalling.
This study unravels how an increased proliferation induced by a common proliferation inducer (sPLA-IIA) alters the fate of normal SCs and cancer cells distinctively through common JNK/c-Jun signalling. Thus, sPLA-IIA can be a potential target for various diseases including cancer. FUND: This work was partly supported by the Indian Council of Medical Research (ICMR-3097) and ACTREC (42) grants.
组织干细胞(SCs)和癌细胞的增殖受许多共同信号机制的调节。这些机制在正常组织稳态和修复过程中暂时平衡增殖和分化事件。然而,这些异常信号机制对SCs 和癌细胞的最终命运的影响仍不清楚。
为了评估 Secretory Phospholipase A-IIA(sPLA-IIA)诱导的异常信号对正常SCs 和癌细胞的功能影响,我们使用了 K14-sPLA-IIA 转基因小鼠毛囊干细胞(HFSCs)、DMBA/TPA 诱导的小鼠皮肤肿瘤组织、人口腔鳞状细胞癌(OSCC)和皮肤鳞状细胞癌(SCC)衍生的细胞系。
我们的研究表明,sPLA-IIA 诱导 HFSCs 的快速增殖,从而改变增殖动力学,导致缓慢循环的 H2BGFP 阳性 HFSCs 完全丧失。有趣的是,通过 JNK 抑制的体内逆转研究显示,脱发后毛发生长明显延迟,证实 sPLA-IIA 通过 JNK/c-Jun 信号促进 HFSCs 增殖。在不同的细胞环境中,我们显示人 OSCC 和小鼠皮肤癌组织中 sPLA-IIA 的表达增加。重要的是,OSCC 和 SCC 细胞系中 sPLA-IIA 敲低细胞的异种移植在 NOD-SCID 小鼠中显示出肿瘤体积的同时减少和 JNK/c-Jun 信号的减少。
这项研究揭示了一种常见的增殖诱导剂(sPLA-IIA)引起的增殖增加如何通过共同的 JNK/c-Jun 信号分别改变正常SCs 和癌细胞的命运。因此,sPLA-IIA 可以成为包括癌症在内的各种疾病的潜在靶点。
这项工作部分得到了印度医学研究理事会(ICMR-3097)和 ACTREC(42)基金的支持。